🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Drug Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the service has taken down violative content and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also found groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.

Within moments of joining one group, a vendor shared contact information, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these groups, messages display black plastic packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen individuals harmed by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject patients to potentially serious health risks”.